Quantcast

Latest Prostate cancer Stories

2014-07-08 08:32:06

New Jersey CyberKnife physicians part of nationwide group analyzing value of RSSearch Registry TOMS RIVER, N.J., July 8, 2014 /PRNewswire/ -- Physicians at New Jersey CyberKnife, a service of Community Medical Center, are part of a group of cancer specialists around the U.S. that have analyzed patient data collected through the RSSearch Registry. The group has confirmed cancer centers participating in the registry are following established guidelines for stereotactic body radiation...

Cycling Could Increase Risk for Erectile Dysfunction, Infertility, Or Prostate Cancer
2014-07-07 03:51:09

Mary Ann Liebert, Inc., Publishers Cycling is a popular activity that offers clear health benefits, but there is an ongoing controversy about whether men who ride have a higher risk of urogenital disorders such as erectile dysfunction, infertility, or prostate cancer. The results of a study of nearly 5,300 male cyclists who participated in the Cycling for Health UK Study are presented in an article in Journal of Men's Health, a peer-reviewed publication from Mary Ann Liebert, Inc.,...

2014-07-04 12:21:24

DUBLIN, July 4, 2014 /PRNewswire/ -- Research and Markets (http://www.researchandmarkets.com/research/8wc8ss/global_urology) has announced the addition of the "Global Urology Devices Market 2014-2018" report to their offering. http://photos.prnewswire.com/prnh/20130307/600769 Urology devices are used for the diagnosis and treatment of disorders associated with male and female urinary tract systems and the male reproductive organs. Urology devices are used for the surgical management of...

2014-07-02 08:27:35

Testosterone Gel (1%), the Generic Equivalent to Vogelxo(TM) (testosterone) Gel, Expected to Increase Access for Patients Who Need It MAPLE GROVE, Minn., July 2, 2014 /PRNewswire/ -- Upsher-Smith Laboratories, Inc., today announced the launch of Testosterone Gel (1%), the generic of the newly Food and Drug Administration (FDA) approved Vogelxo((TM)) (testosterone) gel 1%, for topical use, CIII, and the first and only available generic testosterone replacement therapy (TRT) available in three...

2014-07-01 12:28:02

Conference Committee Report Includes $500k for Public Education Initiative in FY15 Budget, Putting Massachusetts in Lead BOSTON, July 1, 2014 /PRNewswire-USNewswire/ -- The Massachusetts' House of Representatives and Senate today placed the state in a national leadership position by creating a new education and awareness program dedicated to prostate cancer. The $500,000 campaign, contained in the conference committee report of the FY15 budget, is aimed at saving lives, improving...

2014-07-01 10:07:43

University of Pennsylvania School of Medicine Lack of clinical trial data, guidelines on HIV patients with cancer may contribute to health disparity HIV-infected people diagnosed with cancer are two to four times more likely to go untreated for their cancer compared to uninfected cancer patients, according to a new, large retrospective study from researchers in Penn Medicine's Abramson Cancer Center and the National Cancer Institute (NCI) published online ahead of print in the Journal...

2014-07-01 08:29:13

ORCA(TM) program includes seven Phase 2 trials in tumor types where patient need is acute, including bladder, lung, pancreas and prostate cancers BOTHELL, Wash. and VANCOUVER, British Columbia, July 1, 2014 /PRNewswire/ -- OncoGenex Pharmaceuticals, Inc. (NASDAQ: OGXI) today announced initiation of the Cedar(TM) clinical trial, an investigator-sponsored, randomized, open-label Phase 2 trial evaluating apatorsen in previously untreated patients with advanced squamous cell lung cancer....

2014-06-30 23:18:26

UroToday, the leading U.S.-based urology website, launches mCRPC videos. Berkeley, CA (PRWEB) June 30, 2014 In an effort towards advancing knowledge through quality education and engagement, UroToday, the leading U.S.-based urology website, presents exclusive videos on the treatment of metastatic castrate-resistant prostate cancer (mCRPC). These video lectures, offered by leaders across the broad spectrum of the urology and GU oncology specialties, are published in various channels in...

2014-06-30 08:30:19

BALTIMORE, June 30, 2014 /PRNewswire/ -- Goldman Small Cap Research, a stock market research firm focused on the small cap and micro cap sectors, announced today that it has released a new research report on MetaStat, Inc. (OTCQB: MTST). The life sciences company develops and commercializes diagnostic products and novel therapeutics for the early and reliable prediction and treatment of systemic metastasis, the process by which cancer spreads from a primary tumor through the...

2014-06-27 12:26:51

OWINGS MILLS, Md., June 27, 2014 /PRNewswire-USNewswire/ -- In ongoing support of prostate cancer research, Sanford Siegel, M.D., President and CEO of Chesapeake Urology Associates, presented the Urology Care Foundation with a check for $114,248 in support of its prostate cancer research efforts. The funds, which were raised through the Zero Prostate Cancer Challenge (ZPCC) 10K/5K run in September 2013, were presented at the AUA Annual Meeting in Orlando, Florida on May 16, 2014. The...


Word of the Day
drawcansir
  • A blustering, bullying fellow; a pot-valiant braggart; a bully.
This word is named for Draw-Can-Sir, a character in George Villiers' 17th century play The Rehearsal.
Related